Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early TXA in Low Energy Hip Fracture
NCT03182751Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Apr 2018
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tranexamic acid in Intertrochanteric fracture of the femur (ITF), sponsored by Mayo Clinic. Started Apr 2018; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Intertrochanteric fracture of the femur (ITF)
Beyond the preview
Go deeper on NCT03182751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03182751.